# VIGABATRIN
> **ANDA209824** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2018-04-23
## Drug
- **FDA Application Number:** ANDA209824
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VIGABATRIN
- **Generic name:** Vigabatrin
- **Active ingredients:** VIGABATRIN
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS USA
- **First approval:** 2018-04-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209824)
---
*MORVS · CC0 1.0*